Tag Archive for: Tay Therapeutics

partnership

Tay Therapeutics in licensing deal with VYNE Therapeutics

Tay Therapeutics Ltd announces licencing of its oral BET blocker TayB2 to VYNE Therapeutics Inc as a treatment for immuno-inflammatory and fibrotic disorders.

 

Read more